COGHLAN JOHN PHILIP 4
4 · Life360, Inc. · Filed Jul 6, 2026
Research Summary
AI-generated summary of this filing
Life360 (LIF) Director John Coghlan Sells Shares
What Happened
John Philip Coghlan, a director of Life360, Inc. (LIF), sold a total of 4,000 shares of the company's common stock in open-market transactions on July 1, 2026. The sales consisted of 3,798 shares at a weighted-average price of $56.04 (total ≈ $212,840) and 202 shares at a weighted-average price of $56.57 (total ≈ $11,427), for combined proceeds of about $224,267. These were outright sales (not option exercises or awards).
Key Details
- Transaction date: July 1, 2026 (reported on Form 4 filed July 6, 2026).
- Sales:
- 3,798 shares sold at weighted-average $56.04; per-share range reported $55.52–$56.47 (Footnotes F1, F2).
- 202 shares sold at weighted-average $56.57; per-share range reported $56.52–$56.67 (Footnote F3).
- Total shares sold: 4,000; total proceeds ≈ $224,267.
- Footnote F1: The 3,798-share sale was made pursuant to a Rule 10b5-1 trading plan adopted by Coghlan on December 8, 2025.
- Footnotes F2/F3: Prices shown are weighted averages; the reporting person will provide per-transaction price details on request.
- Footnote F4: The reporting person's holdings include 4,840 restricted stock units (each convertible to one share upon vesting) — the filing excerpt provided did not specify total shares owned after the transactions.
- Timeliness: The provided excerpt does not state whether the Form 4 was marked late.
Context
A Rule 10b5-1 trading plan (noted here) is a prearranged plan that allows insiders to sell shares according to a predetermined schedule or formula and is commonly used to avoid questions about trading while in possession of material nonpublic information. Sales by directors are often routine (e.g., diversification or scheduled plan sales) and are different from purchases, which some investors view as a stronger bullish signal. This filing reports open-market sales only; no option exercises, gifts, or awards were reported in the provided data.
Insider Transaction Report
- Sale
Common stock
[F1][F2]2026-07-01$56.04/sh−3,798$212,840→ 24,633 total(indirect: By Trust) - Sale
Common stock
[F1][F3]2026-07-01$56.57/sh−202$11,427→ 24,431 total(indirect: By Trust)
- 5,676
Common stock
[F4] - 55,494(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2025. The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of the Issuer's common stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company.
- [F2]The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $55.52 to $56.47, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
- [F3]The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $56.52 to $56.67, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
- [F4]Includes 4,840 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.